The invention provides methods, compositions, and kits comprising small
interfering RNA (shRNA or siRNA) which are useful for inhibition of
viralmediated gene expression. Small interfering RNAs as described herein
may be used in methods of treatment of HCV infection. ShRNA and siRNA
constructs that target the internal ribosome entry site (IRES) sequence
of HCV are described.